Having trouble accessing articles? Reset your cache.

FDA’s Pazdur supports expanded access for approved drugs

Richard Pazdur, director of FDA’s Oncology Center of Excellence, Wednesday said he supports authorizing expanded access requests for unapproved uses of approved medicines.

Although physicians can prescribe drugs for off-label indications, it can be difficult or impossible

Read the full 379 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE